Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.031
%
−12,02%
Latest
0.227
High
0.256
Low
0.225
Volume
255 097
Turnover (SEK)
59 521
Market Value (MSEK)
66,4
Time (Latest trade)
2024-03-04 12:35

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Anna Törner
  • Johan Drott
  • Kristina Drott

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 8,50 8,50 2023-12-27
Valcuria Holding AB 3,86 3,86 2023-12-27
Ben Hayes 2,32 2,32 2023-12-27
Hans Harvig 1,72 1,72 2023-12-27
Hans Mandahl 1,20 1,20 2023-12-27
Benny Bengtsson 1,09 1,09 2023-12-27
Christian Müller 1,00 1,00 2023-12-27
Göran Lennart Rehn 0,99 0,99 2023-12-27
Hartmut Wiese 0,99 0,99 2023-12-27
Nordnet Pensionsförsäkring 0,84 0,84 2023-12-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream